Evidence map›Paper›PMID 16056238›Full record

ArticleBritish journal of pharmacology2005

Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells.

Shuk Yin M Yeung, Iain A Greenwood

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 98 citations in OpenAlex.

  1. Physiological 17β-oestradiol inhibits KChannels (Austin, Tex.) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. KAmerican journal of physiology. Renal physiology · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Remodeling of Kv7.1 and Kv7.5 Expression in Vascular Tumors.International journal of molecular sciences · 2020
    Article
  12. Article
  13. Pirfenidone Is a Vasodilator: Involvement of KFrontiers in pharmacology · 2020
    Article
  14. Article
  15. Detrusor Smooth Muscle KFrontiers in physiology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. KNaunyn-Schmiedeberg's archives of pharmacology · 2017
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shuk Yin M YeungDepartment of Basic Medical Sciences, St George's University of London, Cranmer Terrace, London SW17 0RE.
Iain A Greenwood
St George's, University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of the KCNQ channel blockers XE991, chromanol 293B and linopirdine, was studied on voltage-dependent K+ currents in smooth muscle cells dissociated freshly from mouse portal vein (mPV) and isometric tension recordings from whole mPV. Voltage clamp experiments showed XE991 inhibited an outward current in a concentration-dependent manner with an IC50 of 5.8 microM. Block was voltage independent. Chromanol 293B and linopirdine also blocked the voltage-dependent K+ current but were less potent than XE991. At least two components--a linear (I(linear)) and an outward relaxation (I(out))--contributed to the XE991-sensitive conductance. XE991-sensitive currents were sustained at all test potentials and XE991 inhibited the enhanced holding current at -60 mV produced by bathing cells in an external solution containing 36 mM KCl. Current clamp experiments in the perforated-patch configuration showed XE991 and linopirdine depolarised the resting membrane potential and augmented the evoked response in a concentration-dependent manner. In functional experiments the spontaneous contractile activity of the mPV was increased significantly by XE991 and linopirdine. The stimulatory effect of XE991 was not affected by the presence of 4-AP, glibenclamide nor paxilline. These data provide evidence for an important role for KCNQ channels in governing cellular excitability in mPV smooth muscle cells.

Indexed as

4-AminopyridineAnimalsAnthracenesChromansDose-Response Relationship, DrugFemaleIndolesIn Vitro TechniquesKCNQ Potassium ChannelsKineticsMembrane PotentialsMiceMice, Inbred BALB CMuscle ContractionMuscle, Smooth, VascularMyocytes, Smooth Muscle10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone4-Aminopyridine6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromaneAnthracenesChromansIndolesKCNQ Potassium ChannelslinopirdinePotassiumPotassium Channel BlockersPyridinesSulfonamides

Identifiers

PMID16056238
PMCPMC1751185
OpenAlexW2081587319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.